SCHEMBL13656209

SCHEMBL13656209

COOSNc1ccc(CCC(=O)NC/C=C/c2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 9/20 0.67
GRIN2B Q13224 9/20 0.67
KCNH2 Q12809 2/20 0.67
PYGL P06737 2/20 0.40
KDM1A O60341 2/20 0.39
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
APAF1 O14727 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
RAD52 P43351 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13656309 0.93 GRIN1 (0.57) GRIN1GRIN2BKCNH2KDM1AHDAC1
SCHEMBL13656130 0.85 GRIN1 (0.69) GRIN1GRIN2BKCNH2HDAC3HDAC4
SCHEMBL12575967 0.84 GRIN1 (0.77) GRIN1GRIN2BKCNH2PYGLFFAR1
SCHEMBL2022155 0.80 GRIN1 (1.00) GRIN1GRIN2BKCNH2PYGL
SCHEMBL2022158 0.80 GRIN1 (1.00) GRIN1GRIN2BKCNH2PYGL
SCHEMBL13656204 0.80 GRIN1 (0.64) GRIN1GRIN2BKCNH2PYGLPOLB
SCHEMBL13656223 0.80 PYGL (0.60) GRIN1GRIN2BKCNH2PYGLPOLB
SCHEMBL13656210 0.78 KMT2A (0.56) GRIN1GRIN2BKCNH2PYGLPOLB
SCHEMBL13656205 0.78 GRIN1 (0.52) GRIN1GRIN2BKCNH2PYGLPOLB
SCHEMBL12576449 0.76 GRIN1 (0.65) GRIN1GRIN2BKCNH2PYGLKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420680-B2 NMDA receptor antagonists for neuroprotection EMORY UNIVERSITY (US) 2013-04-16 US disclosed
US-20090253710-A1 NMDA Receptor Antagonists for Neuroprotection EMORY UNIVERSITY 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253710-A1 NMDA Receptor Antagonists for Neuroprotection GRIN1, GRIN2C, GRIK1 GRIN1 1/4885GRIN2B 7/4885KCNH2 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.